20 Fibromyalgia Clinical Trials in Philadelphia, PA (2026)

Q: How do I join a clinical trial in Philadelphia?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you.

Recruiting Fibromyalgia Studies in Philadelphia

NCT01852448Recruiting

Genetics of Insulin and Incretins in Cystic Fibrosis

Cystic fibrosis related diabetes (CFRD) is associated with worse CF-relevant outcomes. The mechanisms underlying CFRD development are not fully understood, but recent evidence suggests Type 2 Diabete...

Philadelphia, PA550 participantsChildren's Hospital of Philadelphia

View Study Details

NCT02544022Recruiting

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Background: People with neurofibromatosis 1 (NF1) who have plexiform neurofibromas (pNFs) can have pain that affects their daily lives. This study aims to improve questionnaires that measure their pa...

Philadelphia, PA476 participantsNational Cancer Institute (NCI)

View Study Details

NCT07312734Recruiting

Study to Enable New Diagnostics for Pulmonary Microbes in People With CF

Sputum culture has been the best approach to detect harmful bacteria in the lungs of people with cystic fibrosis (CF). With the widespread use of new CF therapies (like Trikafta and Alyftrak), it is m...

Philadelphia, PA300 participantsChris Goss

View Study Details

NCT01401998Recruiting

ARPKD Database Study

Hepato-renal fibrocystic diseases (HRFD) is a term developed that encompasses rare diseases such as Autosomal Recessive Polycystic Kidney Disease (ARPKD), and other diseases with common features (Joub...

Philadelphia, PA200 participantsChildren's Hospital of Philadelphia

View Study Details

NCT07226648Recruiting

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four tre...

Philadelphia, PANA180 participantsSPIRE Therapeutics Inc.

View Study Details

NCT07230288Recruiting

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF) is a rare, long-lasting lung disease that causes scarring of lung tissue, shortness of breath, and loss of lung function. IPF leads to significant loss of quality o...

Philadelphia, PAPHASE2165 participantsAbbVie

View Study Details

NCT06950892Recruiting

Remote Sputum Collection in Cystic Fibrosis

Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections has become more chall...

Philadelphia, PA150 participantsUniversity of Pennsylvania

View Study Details

NCT06089616Recruiting

A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

The participants in this registry study will have fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare, severely disabling disease characterized by new bone formation in areas of the bod...

Philadelphia, PA100 participantsIpsen

View Study Details

NCT05090891Recruiting

To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

This Phase 2, Randomized, Double-Blind, Placebo-Controlled Study is intended to evaluate the Efficacy, Safety, and Tolerability and PK of INCB000928 administered to participants with a clinical diagno...

Philadelphia, PAPHASE298 participantsIncyte Corporation

View Study Details

NCT07201922Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition where lung tissue becomes scarred, making it harder to ...

Philadelphia, PAPHASE380 participantsBoehringer Ingelheim

View Study Details

NCT06705075Recruiting

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

This study goals are to determine the patterns of uterine fibroid vascularity pre and post UAE using CEUS resulting in an alternative to gadolinium-enhanced MRI that is less expensive, has less contra...

Philadelphia, PAPHASE280 participantsThomas Jefferson University

View Study Details

NCT07436351Recruiting

ACT With CF Self-Help Toolkit

Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depressi...

Philadelphia, PANA60 participantsThomas Jefferson University

View Study Details

NCT06413355Recruiting

FAPI-74 PET/CT in Adults With Fibrosis

This protocol is intended as a basket protocol designed to evaluate the use of Fibroblast Activating Protein (FAP) PET/CT in imaging the presence of fibrosis caused by a variety of medical conditions ...

Philadelphia, PAPHASE145 participantsAbramson Cancer Center at Penn Medicine

View Study Details

NCT01851694Recruiting

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

In recent years, diabetes has emerged as one of the most significant co-diseases that many Cystic Fibrosis (CF) patients develop. Type 1 (T1D) and Type 2 (T2D) diabetes results when either the body do...

Philadelphia, PANA45 participantsUniversity of Pennsylvania

View Study Details

NCT05975983Recruiting

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

The goal of this clinical trial is to learn about INS018\_055 in adults with Idiopathic Pulmonary Fibrosis (IPF). The primary objective is to evaluate the safety and tolerability of INS018\_055 orall...

Philadelphia, PAPHASE240 participantsInSilico Medicine Hong Kong Limited

View Study Details

NCT07366034Recruiting

A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)

This study is open to children and adolescents aged 2 to 17 years with interstitial lung disease (ILD). Nerandomilast has just been approved in some countries to help adults with a lung condition call...

Philadelphia, PAPHASE335 participantsBoehringer Ingelheim

View Study Details

NCT04731272Recruiting

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Diabetes is a major co-morbidity in pancreatic insufficient cystic fibrosis (PI-CF) and associated with worse outcomes. While reduced β-cell mass contributes to the insulin secretory defects that char...

Philadelphia, PAPHASE230 participantsUniversity of Pennsylvania

View Study Details

NCT06502171Recruiting

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Based on the clinical activity of both selumetinib and cabozantinib as monotherapies in clinical trials, the demonstrated activity of these agents in reduced doses in preclinical studies, and the non-...

Philadelphia, PAPHASE130 participantsGirish Dhall, MD

View Study Details

NCT06218628Recruiting

Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

This is a prospective phase I dose-escalation study, with the primary objective to access the MTD and find the RP2D of talazoparib, given in combination with standard of care dosing of pacritinib....

Philadelphia, PAPHASE124 participantsFox Chase Cancer Center

View Study Details

NCT06526923Recruiting

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

This is a Phase 1/2 multicenter, open-label, single dose trial of SP-101 investigational gene therapy in adults with CF who are ineligible for or intolerant to CFTR modulator therapy....

Philadelphia, PAPHASE115 participantsSpirovant Sciences, Inc.

View Study Details

About Fibromyalgia Clinical Trials in Philadelphia

Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.

There are currently 20 fibromyalgia clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 2,703 participants. Research is being sponsored by Children's Hospital of Philadelphia, National Cancer Institute (NCI), Chris Goss and 12 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fibromyalgia Clinical Trials in Philadelphia — FAQ

Are there fibromyalgia clinical trials in Philadelphia?

Yes, there are 20 fibromyalgia clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What fibromyalgia treatments are being tested?

The 20 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.

Data updated August 29, 2026 from ClinicalTrials.gov